NCT06626581Not yet recruiting
Iodine Status and Characteristics of Papillary Thyroid Cancer
A Cross-sectional Study on Iodine Status and Characteristics of Papillary Thyroid Cancer
Source: ClinicalTrials.gov · Last updated 4 Oct 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The effect of iodine on papillary thyroid cancer has been controversial for many years. The investigators designed a cross-sectional study and aimed to explore the relationship between the serum and urine iodine levels and the clinical and molecular characteristics of papillary thyroid cancer.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 600 (estimated)
- First submitted
- 25 Sept 2024
- Start date
- 1 Nov 2024
- Primary completion date
- 1 Nov 2026
- Lead sponsor
- Shandong Provincial Hospital
- Diseases
- Thyroid cancer
- NCT number
- NCT06626581
What you commit to
- Study type: Observational
- Planned participants: 600
- From 1 Nov 2024 to the primary completion date, 1 Nov 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Pathological diagnosis of other types of thyroid cancer;
- Diagnosed with other types of cancer;
- There are serious comorbidities of the heart, liver, and kidneys;
Who the study is looking for
- Age range: 18\~65 years old, gender not limited;
- Living in the residential area for at least 5 years;
- Patients diagnosed clinically with thyroid cancer and scheduled for thyroid surgery, with pathological diagnosis of papillary thyroid cancer;
- Complete clinical data: including general information, relevant laboratory tests, pathological reports, surgical reports, ultrasound reports, etc.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.